Combined pegylated liposomal doxorubicin and bortezomib is highly effective in patients with recurrent or refractory multiple myeloma who received prior thalidomide/lenalidomide therapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples